Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study shows public health impact of covid-19 vaccines in the U.S.

by Medical Finance
in Coronavirus
Researchers analyze the role of self-deception in everyday life
9
SHARES
100
VIEWS
Share on FacebookShare on Twitter

A large US study published by The BMJ today finds that fewer people die from covid-19 in better vaccinated communities.

The findings, based on data across 2,558 counties in 48 US states, show that counties with high vaccine coverage had a more than 80% reduction in death rates compared with largely unvaccinated counties.

This large benefit complements the growing body of evidence indicating individual level benefits of covid-19 vaccination. A linked editorial also proposes that encouraging people to keep up to date with vaccination saves lives.

As of 11 April 2022, more than 11 billion covid-19 vaccine doses have been administered globally and the World Health Organization’s target is to vaccinate 70% of the world’s population by mid-2022.

Yet while previous vaccine studies have shown benefits at the individual level, the wider population level impact of scaling up covid-19 vaccination remains largely unknown.

To address this, researchers at the US Centers for Disease Control and Prevention (CDC) set out to estimate how increasing county coverage of vaccines affected population level mortality and incidence of covid-19.

Their findings are based on more than 30 million cases of covid-19 and over 400,000 deaths linked to covid-19 across 2558 counties, which were reported during the second year of the pandemic, between December 2020 and December 2021.

They measured effectiveness by comparing reported covid-19 incidence and mortality rates in counties with very low (0-9%), low (10-39%), medium (40-69%), and high (70% or more) vaccination coverage – defined as the percentage of adults (aged 18 and over) who had received at least one dose of a covid-19 vaccine.

After taking account of potentially influential factors, the researchers found that increased vaccination coverage in counties was associated with reduced levels of covid-19 related mortality and cases.

For example, during the first half of 2021, when the alpha variant of coronavirus was dominant, the covid-19 mortality rate was reduced by 60%, 75%, and 81% in counties with low, medium, and high vaccination coverage, respectively, compared with counties that had very low coverage.

The corresponding figures for the reduction in cases were 57%, 70%, and 80%.

Similar reductions in mortality were also seen during the second half of 2021 when the delta variant became dominant in the US, although with smaller effects on case levels.

This is an observational study, so can’t establish cause and the researchers say several limitations should be considered when interpreting these data. For example, additional markers of severe disease, such as hospital admissions, were not explored and they did not control for factors such as rules on wearing a face mask masking and physical distancing at the time, which may have affected their results.

Nevertheless, they point out that results were similar after further sensitivity analyses, suggesting that they withstand scrutiny. And they say: “Future research may benefit from evaluating macroeconomic effects of improving population health, such as changes in employment rates and gross domestic product resulting from reopening society.”

This study adds to the evidence that vaccination can prevent infection and illness on a large scale, writes Professor Christopher Dye at the University of Oxford in a linked editorial.

The findings of this study also make clear that many more lives could have been saved, and will be saved, by encouraging people to keep up to date with vaccination in the face of waning immunity and new coronavirus variants and by achieving even higher population coverage.”


Christopher Dye, Professor, University of Oxford

“How many lives is a matter for others to explore. Meanwhile, this new study is another confidence booster for covid-19 vaccines,” he concludes.

Source:

Journal reference:

Suthar, A. B., et al. (2022) Public health impact of covid-19 vaccines in the US: observational study. BMJ. doi.org/10.1136/bmj-2021-069317.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals. Image Credit: Puwadol Jaturawutthichai/Shutterstock

Study finds T cell response mostly conserved against SARS-CoV-2 Omicron variant following infection or vaccination

by Medical Finance
May 20, 2022
0

The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown itself to be a very...

Fire closes hospital and displaces staff as Colorado battles omicron

Is my cloth mask good enough? The 2022 edition

by Medical Finance
May 20, 2022
0

The highly transmissible omicron variant is sweeping the U.S., causing a huge spike in covid-19 cases and overwhelming many hospital...

Study: Naïve T cells may be key to the low mortality of children with COVID-19. Image Credit: Martin Lauge Villadsen/Shutterstock

Naïve T cells suggested as critical to low mortality of children with COVID-19

by Medical Finance
May 20, 2022
0

During the ongoing coronavirus disease 2019 (COVID-19) pandemic, a peculiar phenomenon has been observed: younger individuals infected with severe acute...

Study: Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media. Image Credit: vered sh / Shutterstock

Gaseous ozone is effective for SARS-CoV-2 disinfection

by Medical Finance
May 20, 2022
0

In their recent study published in the Journal of Hazardous Materials, researchers from the United Kingdom have found that ozone as...

Study: Comprehensive analysis of disease pathology in immunocompetent and immunocompromised hamster models of SARS-CoV-2 infection. Image Credit: CKA/Shutterstock

COVID-19 symptoms found to vary in different immune contexts

by Medical Finance
May 20, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers studied the kinetics of host response to severe acute...

Study: Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures. Image Credit: SciePro / Shutterstock.com

Assessing how autoantibodies in COVID-19 correlate with anti-viral humoral responses

by Medical Finance
May 20, 2022
0

In a recent study published on the medRxiv* preprint server, a team of researchers screened several systemic autoantibodies to assess...

Next Post
Mutations in SARS-CoV-2 Omicron variant promote cell binding

Mutations in SARS-CoV-2 Omicron variant promote cell binding

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

Study analyzes the impact of global trust in government due to the COVID-19 pandemic

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Persistence of residual SARS-CoV-2 viral antigen and RNA in tissues of patients with long COVID-19. Image Credit: ANDREI_SITURN/Shutterstock
    Study reports persistent SARS-CoV-2 lingering within tissues of patients with long COVID
  • Study: Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia. Image Credit: Nor Gal/Shutterstock
    Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply